XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
OVERLAYS
Fund
Benchmark
3Y · NAV total return · GBP
First Trust Nasdaq Pharmaceuticals ETF: holdings, performance and fees
1Y return+48.4%
3Y return+56.0%
5Y return+73.6%
Top 10 holdings
| Holding | Weight |
|---|---|
| ELI LILLY AND COMPANY | 7.8% |
| ABBVIE INC. | 7.4% |
| MERCK & CO INC NEW | 7.1% |
| JOHNSON & JOHNSON | 7.0% |
| BRISTOL-MYERS SQUIBB COMPANY | 6.3% |
| BIOGEN INC. | 3.8% |
| VIATRIS INC | 3.6% |
| CARDINAL HEALTH, INC. | 3.5% |
| VERTEX PHARMACEUTICALS INCORPORATED | 3.4% |
| AMGEN INC. | 3.2% |
Top countries
- USA95.6%
- Ireland3.8%
- Bermuda0.6%
- Cash & Cash Equivalents0.0%
Holdings, sector and country weightings and performance as reported by FE fundinfo. Weightings are a percentage of the portfolio and may not sum to 100.
AI FORECAST · 12-MONTH
Powered by Claude
FREE PREVIEW
Sign up free to unlock the full AI analysis →
UP—
PREMIUM
PREMIUM
Positives
Risks
600 adviser votes
Unlock the full forecast →
This is an illustrative, model-generated scenario based on stated assumptions. It is not a prediction, a forecast of actual returns, or investment advice. Outcomes may differ materially. Past performance is not a guide to future returns. Capital is at risk.
PORTFOLIO BREAKDOWN